Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+15.6%
5Y CAGR+31.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+15.6%/yr
vs +135.0%/yr prior
5Y CAGR
+31.1%/yr
Recent deceleration
Acceleration
-119.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$8.27M+4.9%
2024$7.89M-2.4%
2023$8.08M+50.9%
2022$5.36M+2.0%
2021$5.25M+145.5%
2020$2.14M+1081.3%
2019$181116.00+3.2%
2018$175579.00-